The ability of 2-amlno-4-hydroy-7-[dibydroxylpropyl-(L-erythro)-5,6,7,8-tetrahydropterinJ ("7-tetrahydroblopterin" or Hyperphenylalaninemia is an abnormality characteristic of a series of diseases that result from an inability to catalyze the first step in the catabolism of phenylalanine-namely, its conversion to tyrosine (1). The most common cause of this abnormality is the absence of active phenylalanine hydroxylase due to a defect in the gene coding for this enzyme (2, 3). Variant forms of this disease have been reported that are caused by genetic defects in either the biosynthesis of the essential pterin cofactor tetrahydrobiopterin (BH4) or its enzymatic regeneration (4). Since BH4 is required for catecholamine and serotonin biosynthesis by tyrosine hydroxylase and tryptophan hydroxylase, respectively (4), patients with these other forms of hyperphenylalaninemia also have a deficiency of biogenic amine neurotransmitters.
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Hyperphenylalaninemia is an abnormality characteristic of a series of diseases that result from an inability to catalyze the first step in the catabolism of phenylalanine-namely, its conversion to tyrosine (1) . The most common cause of this abnormality is the absence of active phenylalanine hydroxylase due to a defect in the gene coding for this enzyme (2, 3) . Variant forms of this disease have been reported that are caused by genetic defects in either the biosynthesis of the essential pterin cofactor tetrahydrobiopterin (BH4) or its enzymatic regeneration (4) . Since BH4 is required for catecholamine and serotonin biosynthesis by tyrosine hydroxylase and tryptophan hydroxylase, respectively (4) , patients with these other forms of hyperphenylalaninemia also have a deficiency of biogenic amine neurotransmitters.
Recently, several patients have been described with a mild form of hyperphenylalaninemia, who have elevated urinary levels of an isomer of BH4, 2-amino-4-hydroxy-7-[1,2-dihydroxypropyl)-(L-erythro)-5,6,7,8-tetrahydropteridine] ("7-tetrahydrobiopterin" or 7-BH4),* and somewhat decreased levels of BH4 (5) . It has been suggested (6, 7) that the accumulation of abnormal amounts of 7-BH4 might be the result of an alteration of the gene coding for 4a-hydroxytetrahydrobiopterin dehydratase (6, 7) . This enzyme catalyzes the dehydration of 4a-hydroxytetrahydrobiopterin (4a-carbinolamine), the form of the pterin that is initially released from the aromatic amino acid hydroxylases after the BH4-dependent hydroxylation of their respective substrates (7) (8) (9) . In vitro, 4a-carbinolamine dehydrates at a rapid rate even in the absence of the dehydratase, but a small percentage of the 4a-carbinolamine rearranges to form the 7-isomer (6, 7). Thus the dehydratase plays the dual role of catalyzing the dehydration and preventing the isomerization ofthe pterin cofactor (7) .
To date, the cause of the observed mild hyperphenylalaninemia in children who excrete 7-BH4 remains unclear. Among the possible reasons for this abnormality are either that the reaction catalyzed by the dehydratase becomes rate-limiting due to the absence of the enzyme or that 7-BH4 itself in some way impairs the phenylalanine hydroxylation reaction. One possible mechanism for such impairment became apparent when we showed that the oxidation of 7-BH4 by phenylalanine hydroxylase in the presence of phenylalanine is 85-90%o uncoupled from the hydroxylation of the substrate (10) . In this report we demonstrate an additional mechanism by which 7-BH4 might impair phenylalanine hydroxylase activity; i.e., 7-BH4 is a potent inhibitor of this reaction. Furthermore, we have examined the effect of 7-BH4 on the reactions catalyzed by tyrosine hydroxylase and tryptophan hydroxylase and have found that although these reactions are inhibited by this pterin in vitro, the inhibition is manifested only at very high concentrations of 7-BH4.
MATERLS AND METHODS L-Phenylalanine, L-tyrosine, NADH, glucose 6-phosphate, glucose-6phosphate dehydrogenase (from Leuconostoc mesenteroides), and m-hydroxylbenzylhydrazine were purchased from Sigma. L-Tryptophan and beef liver catalase were purchased from Calbiochem and Boehringer Mannheim, respectively. Frozen rabbit brains, used in the preparationi of tryptophan hydroxylase, were purchased from Pel-Freez Biologicals. Sheep liver dihydropteridine reductase was purified through the calcium phosphate gel step (11 Proc. Natl. Acad. Sci. USA 89 (1992) as detailed (12) . The hydroxylation of phenylalanine was monitored by either of two methods. The first measured the formation of tyrosine (13) ; the second used a spectrophotometric assay (14) .
Tyrosine Hydroxylase. Pure tyrosine hydroxylase was obtained from cultured pheochromocytoma PC12 cells (15, 16) . The hydroxylation of tyrosine was measured by the 3H20 release method (16, 17) . The phosphorylation of tyrosine hydroxylase by cAMP-dependent protein kinase was performed as described (18) , under conditions that resulted in the incorporation 0.6-0.7 mol of Pi per mol of enzyme subunit.
Tryptophan Hydroxylase. The hind and midbrain sections (including the superior and inferior colliculi and medulla oblongata) were dissected from whole rabbit brains and the tissue was homogenized in 3 vol of 50 mM Tris-HCI (pH 7.5) containing 0.1 M NaCl and 2 mM dithiothreitol. After centrifugation for 40 min at 110,000 x g (4°C), tryptophan hydroxylase was precipitated from the supernatant fraction by dropwise addition ofa solution of 50% acetic acid to a final pH of 4.8. This mixture was stirred for 10 min at 4°C and the acidified mixture was centrifuged for 10 min at 12,000 x g (4°C). The pellet was resolubilized in homogenization buffer; this preparation served as the source of tryptophan hydroxylase used in these studies. The specific activity of this enzyme preparation was -0.35 nmol per min per mg. Tryptophan hydroxylase activity was measured by the fluorometric determination of 5-hydroxytryptophan (19) .
RESULTS
The Kinetic Properties of Phenylalanine Hydroxylase with 7-BH4. Phenylalanine hydroxylase catalyzes the hydroxylation of phenylalanine at a relatively slow rate in the presence of BH4 (14) . This rate can be substantially increased by preactivating the enzyme with its substrate, phenylalanine (20) (21) (22) , or by exposure of the enzyme to certain phospholipids (23), such as lysolecithin (Table 1) . In contrast, when Phenylalanine-dependent tetrahydropterin oxidation by phenylalanine hydroxylase was measured spectrophotometrically. To test for the effect of phenylalanine activation, phenylalanine hydroxylase was preactivated at 26°C for 5 min with 1 mM phenylalanine prior to the assay. To minimize the effect of substrate inhibition on the reaction of phenylalanine hydroxylase with BH4 in the presence of lysolecithin, the concentration ofphenylalanine in the assay was 0.23 mM. All other assays with BH4 contained 1 mM phenylalanine. For reactions containing 6MPH4, 5 mM phenylalanine was included, whereas when 7-BH4 was the cofactor 0.5 mM phenylalanine was included. The concentration of the cofactors BH4, 6MPH4, and 7-BH4 were 100, 250, and 800 ,uM, respectively. With BH4, the concentration of the hydroxylase was 6.6 or 3.3 ,ug/ml for the unactivated and activated enzyme reactions, respectively. With 7-BH4 and 6MPH4, enzyme at 1.7 ,ug/ml was added. 6MPH4 is the cofactor, catalysis proceeds at a rapid rate with or without phenylalanine or lysolecithin preactivation. Similarly, these activation steps appear to have little effect on the rate of catalysis when 7-BH4 is the cofactor; i.e., in this respect, the cofactor activity of 7-BH4 is similar to that of 6MPH4 rather than BH4 (Table 1) . Thus, the rates of the phenylalanine-dependent oxidation of BH4, 6MPH4, and 7-BH4 by phenylalanine hydroxylase show only a small variance when the enzyme has been activated by either phenylalanine or lysolecithin, whereas the oxidation of BH4 is 20-to 35-fold slower when the enzyme has not been activated ( Table 1) . The enzymatic oxidation of7-BH4 is =85% uncoupled (10), indicating that the rate of tyrosine formation in the presence of 7-BH4 is =15% of the rate with BH4 for the fully activated enzyme.t On the other hand, under conditions where phenylalanine hydroxylase has not been preactivated, the rate of tyrosine formation with 7-BH4 as the cofactor is -3 times faster than with BH4 as the cofactor.
The plot of the dependence of initial rate of tetrahydropterin oxidation on the concentration of 7-BH4 with phenylalanine hydroxylase follows classical Michaelis-Menten kinetics with a Km value 60-fold higher than the Km determined for BH4 under comparable conditions (Table 2 ). In contrast, the analogous plot obtained by varying the concentration of phenylalanine is complex ( Fig. 1 ) and displays both cooperativity at low phenylalanine concentrations (Inset) and substrate inhibition at high phenylalanine concentrations. These kinetic characteristics were observed when the concentration of 7-BH4 was maintained at 0.6, 1.0, and 6.9 times its Km. Because of the complexity of the plot, the kinetic constants can only be estimated. A minimum value for the maximum velocity of the enzymatic oxidation of 7-BH4 is =5 t.mol per min per mg and the concentration of phenylalanine required for half-maximal activity is 660 ,uM. This apparent Km for phenylalanine is -20%o the value found when BH4 is the tPhenylalanine hydroxylase requires a tetrahydropterin cofactor to catalyze the hydroxylation of phenylalanine to tyrosine (24, 25) . Since 1 mol of tetrahydropterin is oxidized per mol of phenylalanine hydroxylated when the cofactor is BH4, the rate of the hydroxylation reaction has usually been monitored for the oxidation of NADH during the NADH-dependent regeneration of the tetrahydropterin by dihydropteridine reductase (14) . A 1:1 stoichiometry is also observed when the cofactor analogue 6MPH4 replaces BH4 in the reaction (14) . However, substitution ofother cofactor analogues for BH4 (e.g., 7-methyltetrahydropterin) can result in the uncoupling of the hydroxylation of the substrate from the oxidation of the cofactor (14) . In these cases, phenylalanine hydroxylase partially behaves as a tetrahydropterin oxidase with the net oxidation of the tetrahydropterin exceeding the net hydroxylation of the substrate. The coupled and uncoupled oxidation of tetrahydropterins by phenylalanine hydroxylase appear to proceed by alternative pathways derived from a common enzyme-bound intermediate (26) cofactor ( Table 2 ). The plot of the dependence of initial rate on phenylalanine concentration obtained from direct measurements of tyrosine production had essentially identical characteristics to those in Fig. 1 , except that the value of the rate of hydroxylation is -15% that of the cofactor oxidation as described above.
Inhibition of Phenylalanine Hydroxylase by 7-BH4. Despite the relatively high apparent Km for 7-BH4, this pterin markedly inhibits the phenylalanine-catalyzed conversion ofphenylalanine to tyrosine when BH4 is the cofactor (Fig. 2) . Even at a concentration as low as 1 ,M 7-BH4, an inhibition of >50%o is observed in the presence of5 AM BH4 and saturating phenylalanine. This inhibition increased as a function of 7-BH4 concentration. Preincubation of phenylalanine hydroxylase with phenylalanine to activate the enzyme only slightly decreased the ability of 7-BH4 to inhibit the reaction (Fig. 2, curve b) . On the other hand, increasing the concentration of BH4 10-fold to 50 MM, (-20 times the K.) partially alleviated the inhibition (Fig. 3 , compare curve c with curve d), as did decreasing the concentration of phenylalanine =5-fold to 200 MM (Fig. 3 , compare curve c with curve b). Interestingly, a further decrease in the concentration of phenylalanine to physiological concentrations (-60 1uM) appeared to entirely prevent the inhibition by 7-BH4 (Fig. 3 , compare curve c with curve a).
The Kinetic Properties of Tyrosine Hydroxylase with 7-BH4. Substitution of 7-BH4 for BH4 in the tyrosine hydroxylasedependent hydroxylation reaction of tyrosine changes some ofthe kinetic properties ofthe enzyme (Table 2) . Whereas the plot of the dependence of the initial rate on tyrosine hydroxylation, with BH4 as the cofactor, is typically biphasic and displays severe substrate inhibition at tyrosine concentrations >50 AM (16, 27, 28) , with 7-BH4 as the cofactor, the plot is hyperbolic with no substrate inhibition at concentrations of tyrosine up to 300 MM (data not shown). Consequently, at high substrate levels, the rate of tyrosine hydroxylation with 7-BH4 exceeds that measured with BR4 (data not shown).
The apparent Km for tyrosine in the presence of 7-BH4 is '13-fold higher than the half-maximal substrate concentration determined with the natural cofactor ( Table 2 ). The apparent Km for 7-BH4, measured in the presence of 0.2 mM Phenylalanine activation was performed as described in Table 1 . The concentrations of phenylalanine and BH4 were 0.9 mM and 5 JM, respectively. The 7-BH4 concentration was varied as indicated and activated (4 jug/ml) or nonactivated (17 Ag/ml) phenylalanine hy- The Kinetic Properties of 7-BH4. In the presence of 0.2 tryptophan hydroxylase-cata to 5-hydroxytryptophan witi natural cofactor (data not 7-BH4 is 20-fold higher thau sponding Km for tryptophan i not be determined due to ti reaction and significant sut levels >0.2 mM. 7-BH4 iS hydroxylation of tryptophan BH4 as the cofactor. An II determined when the enzym 0.12 mM tryptophan and 0.1 120 B 7-BH4 as low as 1 FM substantially inhibited the reaction with BH4 even at concentrations of BH4 equal to 2.5 times its Km. Increasing the BH4 concentration diminished the 100 inhibition of 7-BH4, implying that the inhibition is competitive. Decreasing the concentration of phenylalanine also 80-alleviated the inhibition. In fact, at physiological concentrations of phenylalanine (=60 ,M), even a 10-fold excess of 7-BH4, relative to BH4, failed to inhibit the hydroxylation 60-reaction (Fig. 3, curve a) . Further studies are required to determine whether the sensitivity of the 7-BH4 inhibition at 40 high phenylalanine concentrations is related to the substrate inhibition observed in the absence of BH4.
The cause of the hyperphenylalaninemia observed in pa-> 20
tients with an elevated excretion of 7-BH4 is still uncertain.
Our results suggest that the potent inhibition ofphenylalanine in their urine might be expected to prevent 7-BH4 from 4 and 120 ,uM tryptophan. The fill inhibiting phenylalanine hydroxylation. Similarly, increasing 4 was 0.33 nmol per min per mg. BH4 levels could also serve to counteract this inhibition, although to a lesser extent. This effect provides an explanafor BH4 (29) . This phenomenon tion for the decrease in the blood phenylalanine levels of leinthe regulationoftheactivity these patients when they are given BH4 (5).
When the activity was measured
The effect of 7-BH4 on the other two mammalian aromatic sed the expected decrease in the amino acid hydroxylases indicates that 7-BH4 is a weak o 100 ,uM, without a significant competitive inhibitor and a poor substitute for the natural wn). A much more pronounced cofactor in both hydroxylation reactions. With tyrosine hy-,ed when 7-BH4 was substituted droxylase, the apparent Km for 7-BH4 is decreased by or 7-BH4 decreased from 2.2 mM phosphorylation and, therefore, increases competitiveness orylation, without an apparent with BH4. Nonetheless, even after phosphorylation, the high own). Accordingly, at physiolog-IC50 value for 7-BH4 suggests that under physiological con-[100 ,M (30) ], the phosphoryditions, low levels ofthis pterin should have little effect on the Lse decreased the IC5o of 7-BH4 rate of tyrosine hydroxylation. Similarly, our preliminary (Fig. 4A) . Increasing the conresults obtained with tryptophan hydroxylase suggest that caused a corresponding increase the activity of this enzyme also would not be affected by low M, in agreement with the comlevels of 7-BH4 in vivo. Substantial inhibition of either of -ion by 7-BH4 (data not shown).
these enzymes could result in neurological defects arising tTryptophan Hydroxyle with from the impairment of the synthesis of those neurotrans-2 mM tryptophan, the rate of the mitters derived from tyrosine or tryptophan (4) . Such defects lyzed conversion of tryptophan have not, however, been reported in the hyperphenylalaninei 7-BH4 is only 5% that with the mic patients with elevated levels of 7-BH4 (5, 31). shown). The apparent Km for It is currently believed that the increase in excretion of n for BH4 ( Table 2 ). The corre-7-BH4 is due to a genetic defect in 4a-hydroxytetrahydrowith 7-BH4 as the cofactor could biopterin dehydratase (6, 7) . The dehydratase is predomihe low rate of catalysis for this nantly expressed in three tissues: liver, kidney, and the pineal hstrate inhibition at tryptophan gland (32) . Very little dehydratase activity, on the other hand, s also a poor inhibitor of the was found in the brain, where tryptophan hydroxylase and by tryptophan hydroxylase with tyrosine hydroxylase are both expressed, or in the adrenals, C50 for 7-BH4 of 3.3 mM was where relatively high concentrations of tyrosine hydroxylase e was assayed in the presence of are found.t Since 4a-carbinolamine, the proposed precursor 1 mM BH4 (Fig. 4B) . of 7-BH4, has been shown to be the product of BH4 oxidation DISCUSSION The potent inhibition by 7-BH4 of the phenylalanine hydroxylation reaction with BH4 as the cofactor was somewhat surprising in view of the finding that the Km for 7-BH4 is 60-fold greater than that for the natural cofactor. However, at saturating levels of phenylalanine, concentrations of *The pineal gland contains a relatively high concentration of tryptophan hydroxylase. Tryptophan hydroxylase from the pineal gland has several properties that differ from those of the brain enzyme.
Thus, the finding of significant amounts of dehydratase activity in the pineal gland (32) suggests that further studies should be carried out to examine the kinetics of tryptophan hydroxylase from the pineal gland with 7-BH4; 7-BH4 may inhibit this enzyme more strongly than it inhibits the corresponding brain enzyme. by tyrosine hydroxylase during the enzymatic conversion of tyrosine to dopa (33, 34) , the low dehydratase activity in a tissue where tyrosine hydroxylase is found might result in the formation of some 7-BH4. In normal individuals the amount of 7-BH4 that presumably would be formed in the tissues with low dehydratase activity would likely be significantly less than the IC50 values determined for tyrosine and tryptophan hydroxylase and, thus, would not be expected to have a deleterious effect on either activity.
The plot of the dependence of initial rate on phenylalanine concentration with 7-BH4 as the cofactor deviated substantially from a classical rectangular hyperbola, showing cooperativity at low phenylalanine concentrations and marked substrate inhibition at high phenylalanine concentrations (Fig. 1) . The sigmoidal shape of the plot at low phenylalanine concentrations is similar to that reported for the analogous plot with BH4 as the cofactor. For the natural cofactor, this apparent cooperativity has been postulated to be due to the need to activate phenylalanine hydroxylase with phenylalanine prior to catalysis and the ability of BH4 to inhibit this activation (21, 22) . The sigmoidicity of the plot, therefore, suggests that 7-BH4 may also hinder the activation of the enzyme by phenylalanine.
Substrate inhibition with phenylalanine has been reported (23), previously, but to our knowledge, this is the first time it has been observed in the absence of some form of pharmacological preactivation of the enzyme. The substrate inhibition observed in Fig. 1 is also somewhat less marked than that observed previously in the presence of BH4 (23) . For example, the concentration of phenylalanine that allows the highest rate of catalysis (0.5 mM phenylalanine) is approximately twice that reported under the other conditions (23) .
Although with the natural cofactor each ofthese deviations from classical Michaelis-Menten kinetics [i.e., sigmoidal kinetics and substrate inhibition (14) ] have been reported individually, to our knowledge, these two characteristics have not been previously observed together. Thus, these kinetic characteristics of 7-BH4 make it an ideal cofactor to probe certain aspects of the mechanism of phenylalanine hydroxylase.
